AllianceBernstein’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.78M | Buy |
510,355
+4,100
| +0.8% | +$27.3K | ﹤0.01% | 1855 |
|
|
2026
Q1 | $3.54M | Sell |
506,255
-5,300
| -1% | -$29.7K | ﹤0.01% | 1706 |
|
|
2025
Q4 | $3.58M | Hold |
511,555
| – | – | ﹤0.01% | 1702 |
|
|
2025
Q3 | $3.95M | Buy |
511,555
+1,200
| +0.2% | +$9.37K | ﹤0.01% | 1632 |
|
|
2025
Q2 | $4.45M | Sell |
510,355
-1,000
| -0.2% | -$7.25K | ﹤0.01% | 1530 |
|
|
2025
Q1 | $4.07M | Sell |
511,355
-99,490
| -16% | -$1.01M | ﹤0.01% | 1521 |
|
|
2024
Q4 | $5.55M | Sell |
610,845
-44,583
| -7% | -$430K | ﹤0.01% | 1441 |
|
|
2024
Q3 | $6.02M | Buy |
655,428
+415,575
| +173% | +$3.44M | ﹤0.01% | 1438 |
|
|
2024
Q2 | $2.35M | Buy |
239,853
+84,697
| +55% | +$1.03M | ﹤0.01% | 1853 |
|
|
2024
Q1 | $2.34M | Buy |
155,156
+84,432
| +119% | +$1.53M | ﹤0.01% | 1831 |
|
|
2023
Q4 | $1.52M | Buy |
70,724
+2,956
| +4% | +$54.5K | ﹤0.01% | 2072 |
|
|
2023
Q3 | $1.26M | Sell |
67,768
-17,991
| -21% | -$420K | ﹤0.01% | 2119 |
|
|
2023
Q2 | $2.17M | Buy |
85,759
+5,927
| +7% | +$149K | ﹤0.01% | 1855 |
|
|
2023
Q1 | $2.07M | Sell |
79,832
-30,011
| -27% | -$803K | ﹤0.01% | 1854 |
|
|
2022
Q4 | $2.6M | Buy |
109,843
+36,500
| +50% | +$984K | ﹤0.01% | 1763 |
|
|
2022
Q3 | $1.86M | Sell |
73,343
-354
| -0.5% | -$12.4K | ﹤0.01% | 1937 |
|
|
2022
Q2 | $2.45M | Buy |
73,697
+5,564
| +8% | +$236K | ﹤0.01% | 1822 |
|
|
2022
Q1 | $4.91M | Sell |
68,133
-4,461
| -6% | -$321K | ﹤0.01% | 1597 |
|
|
2021
Q4 | $6.67M | Buy |
72,594
+1,371
| +2% | +$164K | ﹤0.01% | 1468 |
|
|
2021
Q3 | $9.03M | Buy |
71,223
+617
| +0.9% | +$89.8K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $11.7M | Buy |
70,606
+7,315
| +12% | +$1.19M | ﹤0.01% | 1149 |
|
|
2021
Q1 | $11.5M | Sell |
63,291
-1,553
| -2% | -$360K | 0.01% | 1135 |
|
|
2020
Q4 | $13M | Sell |
64,844
-99,564
| -61% | -$20.2M | 0.01% | 1015 |
|
|
2020
Q3 | $36M | Sell |
164,408
-550,570
| -77% | -$117M | 0.02% | 634 |
|
|
2020
Q2 | $136M | Sell |
714,978
-719,747
| -50% | -$126M | 0.08% | 227 |
|
|
2020
Q1 | $222M | Sell |
1,434,725
-991,846
| -41% | -$115M | 0.16% | 125 |
|
|
2019
Q4 | $203M | Sell |
2,426,571
-332,119
| -12% | -$25.3M | 0.12% | 161 |
|
|
2019
Q3 | $187M | Buy |
2,758,690
+140,137
| +5% | +$9.22M | 0.12% | 161 |
|
|
2019
Q2 | $174M | Buy |
2,618,553
+10,834
| +0.4% | +$631K | 0.11% | 173 |
|
|
2019
Q1 | $145M | Buy |
2,607,719
+10,095
| +0.4% | +$616K | 0.09% | 204 |
|
|
2018
Q4 | $129M | Buy |
2,597,624
+167,187
| +7% | +$10.2M | 0.1% | 203 |
|
|
2018
Q3 | $210M | Sell |
2,430,437
-758,079
| -24% | -$54M | 0.14% | 153 |
|
|
2018
Q2 | $185M | Sell |
3,188,516
-1,059,069
| -25% | -$51.7M | 0.13% | 160 |
|
|
2018
Q1 | $171M | Sell |
4,247,585
-225,027
| -5% | -$8.49M | 0.12% | 171 |
|
|
2017
Q4 | $156M | Buy |
4,472,612
+607,002
| +16% | +$20.2M | 0.11% | 180 |
|
|
2017
Q3 | $128M | Buy |
3,865,610
+1,072,020
| +38% | +$35.1M | 0.1% | 200 |
|
|
2017
Q2 | $96.9M | Buy |
2,793,590
+507,390
| +22% | +$14.8M | 0.08% | 286 |
|
|
2017
Q1 | $57.2M | Buy |
2,286,200
+1,551,315
| +211% | +$32.3M | 0.05% | 435 |
|
|
2016
Q4 | $12.1M | Buy |
734,885
+706,485
| +2,488% | +$12M | 0.01% | 869 |
|
|
2016
Q3 | $520K | Buy |
28,400
+7,300
| +35% | +$128K | ﹤0.01% | 2521 |
|
|
2016
Q2 | $338K | Buy |
+21,100
| New | +$246K | ﹤0.01% | 2644 |
|
Other funds holding TDOC
VC
AllianceBernstein's TDOC Position: Q2 2026 in Review
AllianceBernstein increased its Teladoc Health (TDOC) stake by 0.81% in Q2 2026, buying an estimated $27.3K and bringing the position to 510,355 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.
AllianceBernstein first reported a position in TDOC in Q2 2016 and has held it in 41 quarters since. The position peaked at $222M in Q1 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.
- AllianceBernstein held 510,355 shares of Teladoc Health worth $2.78M as of Q2 2026.
- AllianceBernstein bought 4,100 Teladoc Health shares in Q2 2026, an estimated $27.3K.
- Teladoc Health made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1855 holding.
- AllianceBernstein first reported a position in Teladoc Health in Q2 2016 and has held it in 41 quarters since.
- AllianceBernstein's Teladoc Health position peaked at $222M in Q1 2020.
- 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.